Intercept Pharmaceuticals reported $8.62M in Stock for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 7.01M 0.87M
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Amarin AMRN:US $ 267.82M 33.14M
Amgen AMGN:US $ 4411M 325M
Biogen BIIB:US $ 1215.4M 136.1M
Bristol Myers Squibb BMY:US $ 2104M 9M
Eli Lilly And LLY:US $ 3893M 7M
Esperion Therapeutics ESPR:US $ 35.65M 1.26M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
IONIS PHARMACEUT IONS:US $ 24.03M 0.77M
Moderna Inc MRNA:US 1.94B 501M
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Novartis NOVN:VX SF 6997M 331M
Ptc Therapeutics PTCT:US $ 15.28M 0.57M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M
YTE INCY:US $ 35.46M 7.55M